BOT:ASX
Botanix Pharmaceuticals Ltd
A$ 0.0090
0.00%
(0.00) Siku 1
11 Nov, 16:10:09 GMT +11 · AUD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya BOT...
Fungua
A$ 0.01
Juu
A$ 0.01
Chini
A$ 0.01
Mtaji wa soko
24.86M
Wastani wa kiasi cha mauzo
10.54M
Kiasi cha mauzo ya hisa
11.23M
Juu kwa wiki 52
A$ 0.15
Chini kwa wiki 52
A$ 0.01
EPS
-A$ 0.03
Hisa za wawekezaji
2.76B
Idadi ya wafanyakazi
11
Fungua
A$ 0.01
Juu
A$ 0.01
Chini
A$ 0.01
Mtaji wa soko
24.86M
Wastani wa kiasi cha mauzo
10.54M
Kiasi cha mauzo ya hisa
11.23M
Juu kwa wiki 52
A$ 0.15
Chini kwa wiki 52
A$ 0.01
EPS
-A$ 0.03
Hisa za wawekezaji
2.76B
Idadi ya wafanyakazi
11
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
FXStreet
·
dakika 32 zilizopita
S&P 500: Higher yields weigh on equities – Deutsche Bank
Stocktwits
·
dakika 39 zilizopita
S&P 500, Nasdaq Futures Rise Premarket — CRWV, GPRO, SPCX, NVDA, NLST Stocks In Focus
The Motley Fool
·
dakika 23 zilizopita
Why the S&P 500 Could Be Heading for a Repeat of 2018
Benzinga
·
dakika 17 zilizopita
Stock Market Today: Dow Jones, S&P 500 Futures Rise as Bessent Urges US-China to 'De-Risk' — CRWV, RGTI
Wasifu
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Kuhusu Botanix Pharmaceuticals Ltd
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi11
Lilianzishwa1984
Makao makuu-
SektaHealth Care
Sekta-
Tovutibotanixpharma.com